vs
Side-by-side financial comparison of Mastech Digital, Inc. (MHH) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $45.5M, roughly 1.6× Mastech Digital, Inc.). Mastech Digital, Inc. runs the higher net margin — 2.1% vs -49.0%, a 51.2% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -10.4%). Mastech Digital, Inc. produced more free cash flow last quarter ($4.3M vs $-84.7M).
Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
MHH vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $45.5M | $70.6M |
| Net Profit | $972.0K | $-34.6M |
| Gross Margin | 28.3% | — |
| Operating Margin | 2.2% | -56.7% |
| Net Margin | 2.1% | -49.0% |
| Revenue YoY | -10.4% | 81958.1% |
| Net Profit YoY | 227.3% | 54.9% |
| EPS (diluted) | $0.08 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $45.5M | — | ||
| Q3 25 | $48.5M | $70.6M | ||
| Q2 25 | $49.1M | — | ||
| Q1 25 | $48.3M | — | ||
| Q4 24 | $50.7M | — | ||
| Q3 24 | $51.8M | — | ||
| Q2 24 | $49.5M | — | ||
| Q1 24 | $46.8M | — |
| Q4 25 | $972.0K | — | ||
| Q3 25 | $941.0K | $-34.6M | ||
| Q2 25 | $135.0K | — | ||
| Q1 25 | $-1.4M | — | ||
| Q4 24 | $297.0K | — | ||
| Q3 24 | $1.9M | — | ||
| Q2 24 | $1.4M | — | ||
| Q1 24 | $-161.0K | — |
| Q4 25 | 28.3% | — | ||
| Q3 25 | 27.8% | — | ||
| Q2 25 | 28.1% | — | ||
| Q1 25 | 26.7% | — | ||
| Q4 24 | 29.0% | — | ||
| Q3 24 | 28.5% | — | ||
| Q2 24 | 28.2% | — | ||
| Q1 24 | 25.9% | — |
| Q4 25 | 2.2% | — | ||
| Q3 25 | 1.7% | -56.7% | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | -3.8% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 4.7% | — | ||
| Q2 24 | 3.4% | — | ||
| Q1 24 | -0.9% | — |
| Q4 25 | 2.1% | — | ||
| Q3 25 | 1.9% | -49.0% | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | -3.0% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 3.6% | — | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | -0.3% | — |
| Q4 25 | $0.08 | — | ||
| Q3 25 | $0.08 | — | ||
| Q2 25 | $0.01 | — | ||
| Q1 25 | $-0.12 | — | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $0.16 | — | ||
| Q2 24 | $0.12 | — | ||
| Q1 24 | $-0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.5M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $89.3M | $503.0M |
| Total Assets | $111.8M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.5M | — | ||
| Q3 25 | $32.7M | $490.9M | ||
| Q2 25 | $27.9M | — | ||
| Q1 25 | $24.7M | — | ||
| Q4 24 | $27.7M | — | ||
| Q3 24 | $23.9M | — | ||
| Q2 24 | $20.6M | — | ||
| Q1 24 | $19.4M | — |
| Q4 25 | $89.3M | — | ||
| Q3 25 | $88.0M | $503.0M | ||
| Q2 25 | $87.8M | — | ||
| Q1 25 | $86.9M | — | ||
| Q4 24 | $87.4M | — | ||
| Q3 24 | $86.5M | — | ||
| Q2 24 | $84.0M | — | ||
| Q1 24 | $81.7M | — |
| Q4 25 | $111.8M | — | ||
| Q3 25 | $112.6M | $577.1M | ||
| Q2 25 | $110.4M | — | ||
| Q1 25 | $110.1M | — | ||
| Q4 24 | $111.5M | — | ||
| Q3 24 | $111.5M | — | ||
| Q2 24 | $107.5M | — | ||
| Q1 24 | $106.1M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $-84.6M |
| Free Cash FlowOCF − Capex | $4.3M | $-84.7M |
| FCF MarginFCF / Revenue | 9.5% | -120.1% |
| Capex IntensityCapex / Revenue | 0.1% | 0.2% |
| Cash ConversionOCF / Net Profit | 4.48× | — |
| TTM Free Cash FlowTrailing 4 quarters | $10.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | — | ||
| Q3 25 | $6.5M | $-84.6M | ||
| Q2 25 | $3.3M | — | ||
| Q1 25 | $-3.0M | — | ||
| Q4 24 | $4.0M | — | ||
| Q3 24 | $3.3M | — | ||
| Q2 24 | $1.2M | — | ||
| Q1 24 | $-1.3M | — |
| Q4 25 | $4.3M | — | ||
| Q3 25 | $6.3M | $-84.7M | ||
| Q2 25 | $3.2M | — | ||
| Q1 25 | $-3.1M | — | ||
| Q4 24 | $3.9M | — | ||
| Q3 24 | $3.2M | — | ||
| Q2 24 | $707.0K | — | ||
| Q1 24 | $-1.6M | — |
| Q4 25 | 9.5% | — | ||
| Q3 25 | 13.0% | -120.1% | ||
| Q2 25 | 6.6% | — | ||
| Q1 25 | -6.4% | — | ||
| Q4 24 | 7.7% | — | ||
| Q3 24 | 6.2% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | -3.4% | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.4% | 0.2% | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | 4.48× | — | ||
| Q3 25 | 6.88× | — | ||
| Q2 25 | 24.41× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.60× | — | ||
| Q3 24 | 1.76× | — | ||
| Q2 24 | 0.85× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MHH
| IT Staffing Services | $37.6M | 83% |
| Data And Analytics Services | $7.8M | 17% |
VRDN
Segment breakdown not available.
